vTv Therapeutics VTVT
NASDAQ VTVT
$20.87 -0.60 (-2.74%)
As of: Nov 12, 2026 · 10:18 AM EST

vTv Therapeutics (VTVT) Return on Invested Capital [ROIC] (2024)

Updated

vTv Therapeutics' Return on Invested Capital [ROIC] came in at -150.12% for Q4 2024, down 24.98 percentage points from the prior quarter.

Analysis

vTv Therapeutics (VTVT) Return on Invested Capital [ROIC] (2024) Analysis & Trends

Going back to Q1 2024, vTv Therapeutics' Return on Invested Capital [ROIC] data covers 4 quarters.

  • The five-year range for quarterly Return on Invested Capital [ROIC] is -3164.49% (Q1 2024) to -98.47% (Q2 2024).
  • Business Quant data shows VTVT's Return on Invested Capital [ROIC] at -125.14% (Q3 2024), -98.47% (Q2 2024) and -3164.49% (Q1 2024) in the three quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 vTv Therapeutics 260.90 Mn -89.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -150.12%
Sep 30, 2024 -125.14%
Jun 30, 2024 -98.47%
Mar 31, 2024 -3,164.49%
API Access

vTv Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=VTVT&period=max&api_key=YOUR_API_KEY